• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于明确定义的树枝状大分子的纳米球状载体进行化疗药物和核酸的靶向细胞内共递送。

Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier.

作者信息

Kaneshiro Todd L, Lu Zheng-Rong

机构信息

Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84108, USA.

出版信息

Biomaterials. 2009 Oct;30(29):5660-6. doi: 10.1016/j.biomaterials.2009.06.026.

DOI:10.1016/j.biomaterials.2009.06.026
PMID:19595449
Abstract

Codelivery of different therapeutics has a potential to efficaciously treat human diseases via their synergetic effects. We have recently developed a new class dendrimers, poly(l-lysine) dendrimers with a silsesquioxane cubic core (nanoglobules). These dendrimers have compact globular and well-defined structures and highly functionalized surfaces, and can be used as versatile carriers for biomedical applications. In this study, a generation-3 (G3) nanoglobular dendrimer was used to conjugate a peptide c(RGDfK) with a PEG spacer for codelivery of doxorubicin (DOX) and siRNA. Doxorubicin (DOX) was coupled to the RGD targeted nanoglobule via a degradable disulfide spacer to give G3-[PEG-RGD]-[DOX]. G3-[PEG-RGD]-[DOX] showed higher cytotoxicity than free DOX at high doses in glioblastoma U87 cells. G3-[PEG-RGD]-[DOX] was further complexed with siRNA and such complexes were readily internalized by U87 cells as shown by confocal microscopy. The siRNA complexes of the targeted conjugate resulted in significantly higher gene silencing efficiency in U87-Luc cells than those of control conjugates G3-[PEG-RGD] and G3-[DOX]. The nanoglobules are promising carriers for the codelivery of nucleic acids and chemotherapeutic agents.

摘要

递送不同的治疗药物有可能通过协同效应有效治疗人类疾病。我们最近开发了一类新型树枝状聚合物,即具有倍半硅氧烷立方核的聚(L-赖氨酸)树枝状聚合物(纳米球)。这些树枝状聚合物具有紧密的球状且结构明确,表面高度功能化,可作为生物医学应用的通用载体。在本研究中,使用第三代(G3)纳米球树枝状聚合物通过聚乙二醇(PEG)间隔基连接肽c(RGDfK),用于共递送阿霉素(DOX)和小干扰RNA(siRNA)。阿霉素(DOX)通过可降解的二硫键间隔基与RGD靶向纳米球偶联,得到G3-[PEG-RGD]-[DOX]。在高剂量下,G3-[PEG-RGD]-[DOX]在胶质母细胞瘤U87细胞中显示出比游离DOX更高的细胞毒性。G3-[PEG-RGD]-[DOX]进一步与siRNA复合,共聚焦显微镜显示此类复合物很容易被U87细胞内化。靶向偶联物的siRNA复合物在U87-Luc细胞中的基因沉默效率显著高于对照偶联物G3-[PEG-RGD]和G

相似文献

1
Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier.使用基于明确定义的树枝状大分子的纳米球状载体进行化疗药物和核酸的靶向细胞内共递送。
Biomaterials. 2009 Oct;30(29):5660-6. doi: 10.1016/j.biomaterials.2009.06.026.
2
Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.聚-L-赖氨酸八(3-氨丙基)倍半硅氧烷树枝状大分子的合成、表征及基因传递:具有精确确定分子结构的纳米球状药物载体
Mol Pharm. 2007 Sep-Oct;4(5):759-68. doi: 10.1021/mp070036z. Epub 2007 Aug 17.
3
RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.RGD 肽修饰的多功能树枝状大分子平台用于药物包封和靶向抑制癌细胞。
Colloids Surf B Biointerfaces. 2015 Jan 1;125:82-9. doi: 10.1016/j.colsurfb.2014.11.004. Epub 2014 Nov 11.
4
Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.多功能乳糖酸修饰的树枝状大分子用于肝癌细胞的靶向药物递送:研究聚乙二醇间隔基的作用
ACS Appl Mater Interfaces. 2014 Sep 24;6(18):16416-25. doi: 10.1021/am504849x. Epub 2014 Sep 12.
5
Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.聚山梨酯 80 修饰的聚(D,L-丙交酯-共-乙交酯)纳米球用于神经胶质瘤细胞的细胞内药物递送。
J Microencapsul. 2011;28(1):29-36. doi: 10.3109/02652048.2010.522258.
6
Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.聚酰胺-胺树枝状大分子/α-环糊精偶联物(第三代,G3)对内源性基因表达的 siRNA 复合物的抑制作用。
Eur J Pharm Sci. 2011 Oct 9;44(3):375-84. doi: 10.1016/j.ejps.2011.08.019. Epub 2011 Aug 28.
7
Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.通过新型 siRNA 聚酰胺-透明质酸复合物使 MVP 敲低从而改变阿霉素在 MCF-7/ADR 细胞内的分布,克服 MCF-7/ADR 细胞的耐药性。
J Control Release. 2012 Oct 28;163(2):136-44. doi: 10.1016/j.jconrel.2012.08.020. Epub 2012 Aug 23.
8
Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.用于药物和基因共递送并具有协同治疗效果的自组装寡肽纳米结构。
Biomaterials. 2009 Jun;30(17):3100-9. doi: 10.1016/j.biomaterials.2009.03.006. Epub 2009 Apr 1.
9
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.基于聚酰胺-胺树枝状大分子的聚乙二醇化双靶向载体治疗脑肿瘤。
Biomaterials. 2011 Jan;32(2):478-87. doi: 10.1016/j.biomaterials.2010.09.002. Epub 2010 Oct 8.
10
RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.RGD 修饰的 PEG-PAMAM-DOX 缀合物:用于脑胶质瘤的体外和体内研究。
Eur J Pharm Biopharm. 2011 Oct;79(2):232-40. doi: 10.1016/j.ejpb.2011.03.025. Epub 2011 Apr 8.

引用本文的文献

1
Organocatalytic synthetic route to esters and their application in hydrosilylation process.酯的有机催化合成路线及其在硅氢化反应过程中的应用。
Sci Rep. 2024 Aug 17;14(1):19108. doi: 10.1038/s41598-024-70036-y.
2
Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy.联合抗癌治疗中核酸和小分子药物的先进策略。
Int J Biol Sci. 2023 Jan 1;19(3):789-810. doi: 10.7150/ijbs.79328. eCollection 2023.
3
Nanocarriers for delivery of siRNA as gene silencing mediator.用于递送作为基因沉默介质的小干扰RNA的纳米载体。
EXCLI J. 2022 Aug 1;21:1028-1052. doi: 10.17179/excli2022-4975. eCollection 2022.
4
Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology.基于纳米颗粒的策略改善治疗性小干扰RNA在精准肿瘤学中的递送
Pharmaceutics. 2022 Jul 29;14(8):1586. doi: 10.3390/pharmaceutics14081586.
5
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases.用纳米药物治疗中枢神经系统疾病:实现基因治疗的承诺。
Adv Sci (Weinh). 2022 Sep;9(26):e2201740. doi: 10.1002/advs.202201740. Epub 2022 Jul 18.
6
Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.用于癌症治疗的新一代多功能纳米医学设计的新兴概念。
Biosci Rep. 2022 Jul 29;42(7). doi: 10.1042/BSR20212051.
7
Craft of Co-encapsulation in Nanomedicine: A Struggle To Achieve Synergy through Reciprocity.纳米医学中的共封装技术:通过相互作用实现协同效应的探索
ACS Pharmacol Transl Sci. 2022 May 2;5(5):278-298. doi: 10.1021/acsptsci.2c00033. eCollection 2022 May 13.
8
Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy.通过叶酸受体靶向的基于普鲁兰多糖的多功能纳米胶束共递送阿霉素和Beclin1的短发夹RNA用于联合癌症治疗
RSC Adv. 2018 May 15;8(32):17710-17722. doi: 10.1039/c8ra01679h. eCollection 2018 May 14.
9
Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects.四面体 DNA 纳米结构在癌症治疗中的有效性:进展与展望。
J Nanobiotechnology. 2021 Dec 7;19(1):412. doi: 10.1186/s12951-021-01164-0.
10
Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging.多面体低聚倍半硅氧烷(POSS)在药物传递、光动力疗法和生物成像中的应用。
Molecules. 2021 Oct 26;26(21):6453. doi: 10.3390/molecules26216453.